SCHEMBL16894617

SCHEMBL16894617

COc1cc(OC)c2c(=O)cc(-c3cc(OC)c(OC)c(OC)c3OC)oc2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 5/20 0.74
▸ KDM4E B2RXH2 5/20 0.62
▸ MEN1 O00255 4/20 0.62
▸ KMT2A Q03164 4/20 0.62
▸ ALDH1A1 P00352 3/20 0.62
▸ ABCG2 Q9UNQ0 3/20 0.62
▸ NPC1 O15118 1/20 0.62
▸ RAB9A P51151 1/20 0.62
▸ PPARG P37231 1/20 0.55
▸ BRD4 O60885 1/20 0.55
▸ TP53 P04637 1/20 0.54
▸ MDM2 Q00987 1/20 0.54
▸ FLT3 P36888 1/20 0.53
▸ ADORA3 P0DMS8 3/20 0.51
▸ CYP1A1 P04798 1/20 0.51
▸ CYP1B1 Q16678 1/20 0.51
▸ POLB P06746 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ RECQL P46063 1/20 0.50
▸ LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22680507 0.88 ABCB1 (0.71) ABCB1KDM4EMEN1KMT2AALDH1A1
SCHEMBL31237667 0.88 ABCB1 (0.71) ABCB1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1422009 0.85 ABCB1 (1.00) ABCB1KDM4EMEN1KMT2AALDH1A1
SCHEMBL1421577 0.85 ABCB1 (0.68) ABCB1KDM4EMEN1KMT2AALDH1A1
SCHEMBL29465904 0.85 ABCB1 (1.00) ABCB1KDM4EMEN1KMT2AALDH1A1
SCHEMBL4165061 0.80 ABCB1 (0.81) ABCB1KDM4EMEN1KMT2AALDH1A1
SCHEMBL26079993 0.80 ABCB1 (0.80) ABCB1KDM4EMEN1KMT2AALDH1A1
SCHEMBL16894639 0.80 ABCB1 (0.83) ABCB1KDM4EMEN1KMT2AALDH1A1
SCHEMBL16894621 0.79 ABCG2 (0.73) ABCB1KDM4EMEN1KMT2AALDH1A1
SCHEMBL7773355 0.78 QPCT (0.53) ABCB1KDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9669003-B2 Use of flavone and flavanone derivatives in preparation of sedative and hypnotic drugs JIN YONGRI (CN) 2017-06-06 — — US claimed
US-20150196529-A1 USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS JIN YONGRI (CN) 2015-07-16 — — US claimed
US-9669003-B2 Use of flavone and flavanone derivatives in preparation of sedative and hypnotic drugs JIN YONGRI (CN) 2017-06-06 — — US disclosed
US-20150196529-A1 USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS JIN YONGRI (CN) 2015-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150196529-A1 USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS CYP2D6, GATAD2A, CYP3A43 ABCB1 218/4885KDM4E 437/4885MEN1 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback